Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oncotic pressure (also called colloid osmotic pressure) describes the osmotic pressure exerted by plasma proteins, especially albumin, within capillaries. It functions to draw water back into the circulation from tissues, counteracting hydrostatic pressure, and thus maintains fluid distribution, vascular volume, and prevents edema. Albumin contributes the greatest portion to plasma oncotic pressure due to its abundance and chemical properties. Clinically, loss of oncotic pressure (from low albumin or protein loss) results in fluid shifts from the blood into tissues, causing swelling (edema) and potentially compromising blood volume and pressure. Maintenance of oncotic pressure is therefore critical to circulatory and tissue fluid homeostasis, but it is not itself a molecular target. Therapeutic strategies to restore oncotic pressure include administration of albumin, management of underlying disease, and use of diuretics.
Albumin: increases plasma oncotic pressure, pulls water into the vasculature; Diuretics: increase urine output, decrease interstitial fluid
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Maintenance of oncotic pressure.